Tecentriq (atezolizumab) supply for hospitals & distributors

PD-L1 immune checkpoint inhibitor (monoclonal antibody) · Roche

Tecentriq (atezolizumab) is Roche's anti-PD-L1 antibody. It is given by intravenous infusion and, in markets where approved, as a subcutaneous injection co-formulated with hyaluronidase.

اقرأ هذه الصفحة بالعربية

Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.

Product facts

Active substanceatezolizumab

ClassPD-L1 immune checkpoint inhibitor (monoclonal antibody)

Manufacturer (marketing authorisation holder)Roche

RouteIntravenous infusion or subcutaneous injection

Strengths and presentation

840 mg/14 mL concentrate for solution for infusion
1200 mg/20 mL concentrate for solution for infusion
1875 mg/15 mL solution for subcutaneous injection (market-dependent)

Approved indications (EMA / FDA label summary)

Non-small cell lung cancer (adjuvant, first-line and later lines)
Extensive-stage small cell lung cancer, with carboplatin and etoposide
Unresectable hepatocellular carcinoma, with bevacizumab (Avastin)
Urothelial carcinoma and PD-L1-positive triple-negative breast cancer (label-dependent)

Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.

Storage and cold chain

Store refrigerated at 2–8 °C in the original carton to protect from light
Do not freeze; do not shake
Shipped in validated cold-chain packaging with temperature data logging

How we supply

Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
Validated 2–8 °C cold-chain shipping with a temperature data logger from origin to handover.
Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.

Procurement notes

The 1200 mg vial matches the every-3-weeks flat dose and is the presentation most hospitals order. For the hepatocellular carcinoma protocol, bevacizumab can be sourced alongside Tecentriq in the same consignment.

Who we supply

Hospital pharmacy and procurement departments
Licensed pharmaceutical distributors and importers
Oncology and haematology centres
Treating physicians arranging named-patient supply

Markets served

United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.

Frequently asked questions

Do you supply Tecentriq 840 mg or 1200 mg?

Both IV presentations can be sourced. 1200 mg/20 mL is the most frequently requested; 840 mg suits the every-2-weeks schedule.

Can Tecentriq be shipped with Avastin?

Yes. For the atezolizumab–bevacizumab protocol both Roche products can be quoted and shipped together under cold chain.

Is the Tecentriq you supply an original manufacturer pack?

Yes. We supply Tecentriq only in the original Roche pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.

Which documents come with a consignment?

Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.

Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?

Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.

How do I get a quote for Tecentriq?

Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.

Send a supply inquiry

Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.

Send a supply inquiry

Other medicines we supply to the Gulf

Sources

EMA — Tecentriq EPAR / SmPC

Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04